Topical dorzolamide for macular edema in the early phase after vitrectomy and epiretinal membrane removal

Overview of attention for article published in Clinical Ophthalmology, April 2013

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 1 news outlet

Citations

dimensions_citation: 24 Dimensions

Readers on

mendeley: 15 Mendeley

Summary News Dimensions citations

So far, Dimensions has found 24 publications that cite this research output.

24

The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.

Optical coherence tomography biomarkers as outcome predictors to guide dexamethasone implant use in patients with iERM: a randomized controlled trial

Article in BMC Ophthalmology (April 2024)

Topical Dorzolamide as Adjunctive Treatment With Intravitreal Bevacizumab in Bilateral Diabetic Macular Edema

Article in Cureus (February 2024)

The effect of combination therapy with intravitreal bevacizumab and topical timolol–dorzolamide eye drops on diabetic macular edema: a double-blind randomized controlled trial

Article in International Ophthalmology (February 2024)